With respect to MetS−, MetS+ patients were more obese, had greater waist to hip ratio, and had higher baseline serum TG, apo B, Apo A-I/HDL-C ratio, BG, plasma insulin, and HOMAIR and lower HDL-C and apo A-I. This evidence concerns the gene APOB and metabolic syndrome.